Your session is about to expire
← Back to Search
Life After Breast Cancer - Impact of a Life Coach (Lifecoach Trial)
N/A
Waitlist Available
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to help women who have completed breast cancer treatment by providing life coaching. The coaching includes both group and one-on-one sessions to improve their quality of life and reduce fear of cancer coming back.
Eligible Conditions
- Breast Cancer
- Survivorship
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from baseline Post-traumatic growth (PTG) assessed by the Post-Traumatic Growth Inventory (PTGI)
Secondary study objectives
Change from baseline Fear of cancer recurrence (FCR) assessed by the Cancer Worry Scale (CWS)
Change from baseline Quality of life (QoL) assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS)-Preference
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Arm 2 - Group onlyExperimental Treatment1 Intervention
Arm 2 will receive only the first 3 Life coach sessions (group session).
Group II: Arm 1 - Group and IndividualExperimental Treatment2 Interventions
Participants in this experimental Arm 1 will receive the 3 group sessions followed by 4 to 5 individual coaching sessions via phone calls that last 60 minutes each.
Group III: Arm 3 - Routine careActive Control1 Intervention
Arm 3 will receive routine care by the Breast clinic team for the entire course of the study.
Find a Location
Who is running the clinical trial?
McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
470 Previous Clinical Trials
166,824 Total Patients Enrolled
Quebec Breast Cancer FoundationOTHER
6 Previous Clinical Trials
772 Total Patients Enrolled